+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Europe Hemostats Market Size, Share & Industry Trends Analysis Report By Application, By Formulation (Matrix & Gel, Sheet & Pad, Powder, Sponge, and Others), By Type, By Country and Growth Forecast, 2022 - 2028

  • PDF Icon


  • 107 Pages
  • July 2022
  • Region: Europe
  • Marqual IT Solutions Pvt. Ltd (KBV Research)
  • ID: 5645702
The Europe Hemostats Market is expected to witness market growth of 4.9% CAGR during the forecast period (2022-2028).

The prevalence of lifestyle diseases like obesity, arthritis, osteoporosis, and others are also some factors increasing the demand for hemostat.  Long-term drugs are combined with surgical techniques, such as the use of hemostats, to address certain diseases. Additionally, the use of such products in surgical operations requires the assistance of qualified medical specialists. Another motivating element is the increase in demand for hemostatic forceps.

Hemostats serve three purposes in the treatment of severe wounds. Hemostats were initially made to clamp tiny blood arteries to stop bleeding. To grip and hold onto superficial fascia while eroding and debriding wounds is another usage. The deeper regions of a wound can be exposed, explored, and visualized using this equipment. In the treatment of wounds, there are two main types of hemostats. It is advised to use a conventional hemostat for all purposes. The 5-inch curved mosquito hemostat with fine-toothed serrated jaws is frequently the best choice for finer work in small wounds.

The rise in surgical operations is probably what is driving the hemostats market in Europe to grow. Some other factors driving the European hemostatic market include the broad range of applications, ongoing improvements in the product line, technological innovations that benefit end-users, and assurance support for manufacturers to boost tissue sealants. The number of therapies is also growing as a result of chronic diseases and an aging population. The adoption of these devices is also expected to rise as the spending by healthcare private as well as public institutions is increasing. Additionally, there is room for lucrative opportunities due to unfulfilled medical demands and changing market dynamics in the healthcare sector.

The Germany market dominated the Europe Hemostats Market by Country in 2021, and is expected to continue to be a dominant market till 2028; thereby, achieving a market value of $241.8 million by 2028. The UK market is anticipated to grow at a CAGR of 4.1% during (2022 - 2028). Additionally, The France market is expected to exhibit a CAGR of 5.7% during (2022 - 2028).

Based on Application, the market is segmented into Orthopedic Surgery, General Surgery, Neurological Surgery, Cardiovascular Surgery, Reconstructive Surgery, Gynecological Surgery, and Others. Based on Formulation, the market is segmented into Matrix & Gel, Sheet & Pad, Powder, Sponge, and Others. Based on Type, the market is segmented into Thrombin Based, Combination, Oxidized Regenerated Cellulose Based, Gelatin Based, Collagen Based, and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Becton, Dickinson and Company, Baxter International, Inc., B. Braun Melsungen AG, Teleflex, Inc., Medtronic PLC, Johnson & Johnson, Pfizer, Inc., Stryker Corporation, Integra LifeSciences Holdings Corporation, and Artivion, Inc.

Scope of the Study

Market Segments Covered in the Report:

By Application

  • Orthopedic Surgery
  • General Surgery
  • Neurological Surgery
  • Cardiovascular Surgery
  • Reconstructive Surgery
  • Gynecological Surgery
  • Others

By Formulation

  • Matrix & Gel
  • Sheet & Pad
  • Powder
  • Sponge
  • Others

By Type

  • Thrombin Based
  • Combination
  • Oxidized Regenerated Cellulose Based
  • Gelatin Based
  • Collagen Based
  • Others

By Country

  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe

Key Market Players

List of Companies Profiled in the Report:

  • Becton, Dickinson and Company
  • Baxter International, Inc.
  • B. Braun Melsungen AG
  • Teleflex, Inc.
  • Medtronic PLC
  • Johnson & Johnson
  • Pfizer, Inc.
  • Stryker Corporation
  • Integra LifeSciences Holdings Corporation
  • Artivion, Inc.

Unique Offerings from the Publisher

  • Exhaustive coverage
  • The highest number of Market tables and figures
  • Subscription-based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Hemostats Market, by Application
1.4.2 Europe Hemostats Market, by Formulation
1.4.3 Europe Hemostats Market, by Type
1.4.4 Europe Hemostats Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Europe Hemostats Market by Application
3.1 Europe Orthopedic Surgery Market by Country
3.2 Europe General Surgery Market by Country
3.3 Europe Neurological Surgery Market by Country
3.4 Europe Cardiovascular Surgery Market by Country
3.5 Europe Reconstructive Surgery Market by Country
3.6 Europe Gynecological Surgery Market by Country
3.7 Europe Others Market by Country
Chapter 4. Europe Hemostats Market by Formulation
4.1 Europe Matrix & Gel Market by Country
4.2 Europe Sheet & Pad Market by Country
4.3 Europe Powder Market by Country
4.4 Europe Sponge Market by Country
4.5 Europe Others Market by Country
Chapter 5. Europe Hemostats Market by Type
5.1 Europe Thrombin Based Market by Country
5.2 Europe Combination Market by Country
5.3 Europe Oxidized Regenerated Cellulose Based Market by Country
5.4 Europe Gelatin Based Market by Country
5.5 Europe Collagen Based Market by Country
5.6 Europe Others Market by Country
Chapter 6. Europe Hemostats Market by Country
6.1 Germany Hemostats Market
6.1.1 Germany Hemostats Market by Application
6.1.2 Germany Hemostats Market by Formulation
6.1.3 Germany Hemostats Market by Type
6.2 UK Hemostats Market
6.2.1 UK Hemostats Market by Application
6.2.2 UK Hemostats Market by Formulation
6.2.3 UK Hemostats Market by Type
6.3 France Hemostats Market
6.3.1 France Hemostats Market by Application
6.3.2 France Hemostats Market by Formulation
6.3.3 France Hemostats Market by Type
6.4 Russia Hemostats Market
6.4.1 Russia Hemostats Market by Application
6.4.2 Russia Hemostats Market by Formulation
6.4.3 Russia Hemostats Market by Type
6.5 Spain Hemostats Market
6.5.1 Spain Hemostats Market by Application
6.5.2 Spain Hemostats Market by Formulation
6.5.3 Spain Hemostats Market by Type
6.6 Italy Hemostats Market
6.6.1 Italy Hemostats Market by Application
6.6.2 Italy Hemostats Market by Formulation
6.6.3 Italy Hemostats Market by Type
6.7 Rest of Europe Hemostats Market
6.7.1 Rest of Europe Hemostats Market by Application
6.7.2 Rest of Europe Hemostats Market by Formulation
6.7.3 Rest of Europe Hemostats Market by Type
Chapter 7. Company Profiles
7.1 Becton, Dickinson and Company
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental and Regional Analysis
7.1.4 Research & Development Expense
7.1.5 SWOT Analysis
7.2 Baxter International, Inc.
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Regional Analysis
7.2.4 Research & Development Expense
7.2.5 Recent strategies and developments: Acquisition and Mergers:
7.3 B. Braun Melsungen AG
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Segmental and Regional Analysis
7.3.4 Research & Development Expenses
7.4 Teleflex, Inc.
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Segmental and Regional Analysis
7.4.4 Research & Development Expense
7.4.5 Recent strategies and developments: Acquisition and Mergers:
7.5 Medtronic PLC
7.5.1 Company overview
7.5.2 Financial Analysis
7.5.3 Segmental and Regional Analysis
7.5.4 Research & Development Expenses
7.5.5 Recent strategies and developments: Acquisition and Mergers:
7.5.6 SWOT Analysis
7.6 Johnson & Johnson
7.6.1 Company Overview
7.6.2 Financial Analysis
7.6.3 Segmental &Regional Analysis
7.6.4 Research & Development Expenses
7.6.5 Recent strategies and developments: Geographical Expansions:
7.6.6 SWOT Analysis
7.7 Pfizer, Inc.
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Regional & Segmental Analysis
7.7.4 Research & Development Expense
7.8 Stryker Corporation
7.8.1 Company Overview
7.8.2 Financial Analysi9
7.8.3 Segmental and Regional Analysis
7.8.4 Research & Development Expense
7.9 Integra LifeSciences Holdings Corporation
7.9.1 Company Overview
7.9.2 Financial Analysis
7.9.3 Segmental & Regional Analysis
7.9.4 Research & Development Expenses
7.10. Artivion, Inc. (CryoLife, Inc.)
7.10.1 Company Overview
7.10.2 Financial Analysis
7.10.3 Segmental and Regional Analysis
7.10.4 Research & Development Expenses

Companies Mentioned

  • Becton, Dickinson and Company
  • Baxter International, Inc.
  • B. Braun Melsungen AG
  • Teleflex, Inc.
  • Medtronic PLC
  • Johnson & Johnson
  • Pfizer, Inc.
  • Stryker Corporation
  • Integra LifeSciences Holdings Corporation
  • Artivion, Inc.